• Select your country/language
  • New Zealand
  • Argentina
  • Australia
  • Belgique (Belgium) - Français
  • België (Belgium) – Nederlands
  • Brasil (Brazil)
  • Canada – English
  • Canada – French
  • Chile
  • Colombia
  • Deutschland (Germany)
  • France – Français
  • Italia
  • Japan - 日本
  • Magyarország (Hungary)
  • México
  • Nederland (Netherlands)
  • Norge (Norway)
  • Panamá
  • Perú
  • Poland
  • Portugal
  • Puerto Rico
  • România (Romania)
  • Schweiz (Switzerland) - Deutsch
  • South Africa
  • Spain
  • Suisse (Switzerland) – Français
  • Suomi (Finland)
  • Svizzera (Switzerland) – Italiano
  • Sweden
  • Türkiye (Turkey)
  • United Kingdom
  • United States
  • Österreich (Austria)
  • Česká republika (Czech Republic)
  • Ελλάδα (Greece)
  • Российская Федерация (Russia)
Share
  • Select your country/language
  • New Zealand
  • Argentina
  • Australia
  • Belgique (Belgium) - Français
  • België (Belgium) – Nederlands
  • Brasil (Brazil)
  • Canada – English
  • Canada – French
  • Chile
  • Colombia
  • Deutschland (Germany)
  • France – Français
  • Italia
  • Japan - 日本
  • Magyarország (Hungary)
  • México
  • Nederland (Netherlands)
  • Norge (Norway)
  • Panamá
  • Perú
  • Poland
  • Portugal
  • Puerto Rico
  • România (Romania)
  • Schweiz (Switzerland) - Deutsch
  • South Africa
  • Spain
  • Suisse (Switzerland) – Français
  • Suomi (Finland)
  • Svizzera (Switzerland) – Italiano
  • Sweden
  • Türkiye (Turkey)
  • United Kingdom
  • United States
  • Österreich (Austria)
  • Česká republika (Czech Republic)
  • Ελλάδα (Greece)
  • Российская Федерация (Russia)
  • Menu
  • Products
  • Share
  • New Zealand
Minimally Invasive Therapies Products Cerebral/Somatic Oximetry INVOS™ Perspective Patient Outcomes

INVOS™ Perspective
  • Patient Outcomes
  • Resources

Patient Outcomes

Make the informed choice for better patient outcomes

Here's why:

  • The INVOS™ system is the clinical standard.([FOOTNOTE=Tomlin et al. Detection of critical cerebral desaturation thresholds by three regional oximeters during hypoxia: a pilot study in healthy volunteers. BMC Anesthesiology 2017, 17:6.],[ANCHOR=],[LINK=]),([FOOTNOTE=Borg U, A faster and deeper response to hypoxia. White paper 2018.],[ANCHOR=],[LINK=])
  • All NIRS Technology is not the same.
  • The INVOS™ system offers a measure of rSO2 not available with other oximeters.
  • Get the "absolute" facts.
  • Customised care for each patient's "normal" is critical.

NIRS Technology

The Only NIRS Technology with Improved Patient Outcomes Labeling

  • The only cerebral oximeter on the market to be tested and validated under varying levels of CO2.
  • Documented clinical performance.
  • Clinical studies using the INVOS™ system demonstrate decreased occurrence of postoperative complications and improved outcomes.([FOOTNOTE=Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007;104(1):51-58.],[ANCHOR=],[LINK=]),([FOOTNOTE=Goldman S, Sutter F, Ferdinand F, Trace C. Optimizing intraoperative cerebral oxygen delivery using noninvasive cerebral oximetry decreases the incidence of stroke for cardiac surgical patients. Heart Surg Forum. 2004;7(5):E376-381.],[ANCHOR=],[LINK=])

INVOS™ RESOURCES

View supporting studies and resources.

About Medtronic
  • Medtronic Corporate ANZ
  • Privacy Statement
  • Terms of Use
  • Terms & Conditions of Supply
  • External Research Program
Minimally Invasive Therapies
  • Products
  • Terms & Conditions of Supply
  • Sitemap
  • Australia/New Zealand Customer Service
Country Office

Level 3 - Building 5

Central Corporate Centre

666 Great South Road

Penrose, Auckland

New Zealand

©2021 Medtronic